<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37073502</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>19</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2162-3279</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>6</Issue><PubDate><Year>2023</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Brain and behavior</Title><ISOAbbreviation>Brain Behav</ISOAbbreviation></Journal><ArticleTitle>Type 2 diabetes, obesity, and risk of amyotrophic lateral sclerosis: A population-based cohort study.</ArticleTitle><Pagination><StartPage>e3007</StartPage><MedlinePgn>e3007</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e3007</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1002/brb3.3007</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Type 2 diabetes and obesity may be inversely associated with amyotrophic lateral sclerosis (ALS), but the evidence is controversial.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Using Danish, nationwide registries (1980-2016), we identified patients with a diagnosis of type 2 diabetes (N&#xa0;=&#xa0;295,653) and patients with a diagnosis of obesity (N&#xa0;=&#xa0;312,108). Patients were matched (1:3) to persons from the general population on birth year and sex. We computed incidence rates and Cox regression derived hazard ratios (HRs) of a diagnosis of ALS. In multivariable analyses, HRs were controlled for sex, birth year, calendar year, and comorbidities.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We observed 168 incident cases of ALS (0.7 [95% confidence interval (CI): 0.6-0.8] per 10,000 person-years) among patients with type 2 diabetes and 859 incident cases of ALS (0.9 [95% CI: 0.9-1.0] per 10,000 person-years) among matched comparators. The adjusted HR was 0.87 (95% CI: 0.72-1.04). The association was present among men (adjusted HR: 0.78 [95% CI: 0.62-0.99]) but not women (adjusted HR: 1.03 [95% CI: 0.78-1.37]), and among those aged &#x2265;60 years (adjusted HR: 0.75 [95% CI: 0.59-0.96]) but not younger. We observed 111 ALS events (0.4 [95% CI: 0.4-0.5] per 10,000 person-years) among obesity patients and 431 ALS events (0.5 [95% CI: 0.5-0.6] per 10,000 person-years) among comparators. The adjusted HR was 0.88 (95% CI: 0.70-1.11).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Diagnoses of type 2 diabetes and obesity were associated with a reduced rate of ALS compared with general population comparators, particularly among men and patients aged 60 years or above. However, absolute rate differences were small.</AbstractText><CopyrightInformation>&#xa9; 2023 The Authors. Brain and Behavior published by Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Skajaa</LastName><ForeName>Nils</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0001-8351-7133</Identifier><AffiliationInfo><Affiliation>Department of Clinical Epidemiology, Aarhus University Hospital and Aarhus University, Aarhus, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Riahi</LastName><ForeName>Emil Bjerregaard</ForeName><Initials>EB</Initials><AffiliationInfo><Affiliation>Department of Clinical Epidemiology, Aarhus University Hospital and Aarhus University, Aarhus, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sz&#xe9;pligeti</LastName><ForeName>Szimonetta Komj&#xe1;thin&#xe9;</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>Department of Clinical Epidemiology, Aarhus University Hospital and Aarhus University, Aarhus, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Horv&#xe1;th-Puh&#xf3;</LastName><ForeName>Erzs&#xe9;bet</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Clinical Epidemiology, Aarhus University Hospital and Aarhus University, Aarhus, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>S&#xf8;rensen</LastName><ForeName>Trine Toft</ForeName><Initials>TT</Initials><AffiliationInfo><Affiliation>Institute of Public Health, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Henderson</LastName><ForeName>Victor W</ForeName><Initials>VW</Initials><AffiliationInfo><Affiliation>Department of Clinical Epidemiology, Aarhus University Hospital and Aarhus University, Aarhus, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology and Population Health, Stanford University, Stanford, California.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology and Neurological Sciences, Stanford University, Stanford, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>S&#xf8;rensen</LastName><ForeName>Henrik Toft</ForeName><Initials>HT</Initials><AffiliationInfo><Affiliation>Department of Clinical Epidemiology, Aarhus University Hospital and Aarhus University, Aarhus, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Excellence Research Center, Stanford University, Stanford, California.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Brain Behav</MedlineTA><NlmUniqueID>101570837</NlmUniqueID></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003924" MajorTopicYN="Y">Diabetes Mellitus, Type 2</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009765" MajorTopicYN="N">Obesity</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">cohort study</Keyword><Keyword MajorTopicYN="N">diabetes</Keyword><Keyword MajorTopicYN="N">obesity</Keyword><Keyword MajorTopicYN="N">population-based</Keyword></KeywordList><CoiStatement>The Department of Clinical Epidemiology, Aarhus University Hospital, receives funding for other studies from companies in the form of research grants to (and administered by) Aarhus University. None of these studies has any relation to the present study.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>3</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>19</Day><Hour>13</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>19</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>19</Day><Hour>3</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37073502</ArticleId><ArticleId IdType="pmc">PMC10275529</ArticleId><ArticleId IdType="doi">10.1002/brb3.3007</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Andersen, P. K. , Geskus, R. B. , de Witte, T. , &amp; Putter, H. (2012). Competing risks in epidemiology: Possibilities and pitfalls. International Journal of Epidemiology, 41(3), 861&#x2013;870. 10.1093/ije/dyr213</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyr213</ArticleId><ArticleId IdType="pmc">PMC3396320</ArticleId><ArticleId IdType="pubmed">22253319</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown, R. H. , &amp; Al&#x2010;Chalabi, A. (2017). Amyotrophic lateral sclerosis. New England Journal of Medicine, 377(2), 162&#x2013;172. 10.1056/NEJMra1603471</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1603471</ArticleId><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>Carstensen, B. , Kristensen, J. K. , Marcussen, M. M. , &amp; Borch&#x2010;Johnsen, K. (2011). The national diabetes register. Scandinavian Journal of Public Health, 39(7), Suppl 58&#x2013;61. 10.1177/1403494811404278</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1403494811404278</ArticleId><ArticleId IdType="pubmed">21775353</ArticleId></ArticleIdList></Reference><Reference><Citation>Christensen, D. H. , Rungby, J. , &amp; Thomsen, R. W. (2016). Nationwide trends in glucose&#x2010;lowering drug use, Denmark, 1999&#x2013;2014. Clinical Epidemiology, 8, 381&#x2013;387. 10.2147/CLEP.S113211</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/CLEP.S113211</ArticleId><ArticleId IdType="pmc">PMC5072551</ArticleId><ArticleId IdType="pubmed">27789974</ArticleId></ArticleIdList></Reference><Reference><Citation>de Jong, S. W. , Huisman, M. H. B. , Sutedja, N. A. , van der Kooi, A. J. , de Visser, M. , Schelhaas, H. J. , Fischer, K. , Veldink, J. H. , &amp; van den Berg, L. H. (2012). Smoking, alcohol consumption, and the risk of amyotrophic lateral sclerosis: A population&#x2010;based study. American Journal of Epidemiology, 176(3), 233&#x2013;239. 10.1093/aje/kws015</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kws015</ArticleId><ArticleId IdType="pubmed">22791740</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Aguila, M. A. , Longstreth, W. T. , McGuire, V. , Koepsell, T. D. , &amp; van Belle, G. (2003). Prognosis in amyotrophic lateral sclerosis: A population&#x2010;based study. Neurology, 60(5), 813&#x2013;819. 10.1212/01.wnl.0000049472.47709.3b</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000049472.47709.3b</ArticleId><ArticleId IdType="pubmed">12629239</ArticleId></ArticleIdList></Reference><Reference><Citation>D'Ovidio, F. , d&#x2019; Errico, A. , Carn&#xe0;, P. , Calvo, A. , Costa, G. , &amp; Chi&#xf2;, A. (2018). The role of pre&#x2010;morbid diabetes on developing amyotrophic lateral sclerosis. European Journal of Neurology, 25(1), 164&#x2013;170. 10.1111/ene.13465</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.13465</ArticleId><ArticleId IdType="pubmed">28921834</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis, L. , Corcia, P. , Fergani, A. , Gonzalez De Aguilar, J. L. , Bonnefont&#x2010;Rousselot, D. , Bittar, R. , Seilhean, D. , Hauw, J. J. , Lacomblez, L. , Loeffler, J. P. , &amp; Meininger, V. (2008). Dyslipidemia is a protective factor in amyotrophic lateral sclerosis. Neurology, 70(13), 1004&#x2013;1009. 10.1212/01.wnl.0000285080.70324.27</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000285080.70324.27</ArticleId><ArticleId IdType="pubmed">18199832</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis, L. , Pradat, P.&#x2010;F. , Ludolph, A. C. , &amp; Loeffler, J.&#x2010;P. (2011). Energy metabolism in amyotrophic lateral sclerosis. Lancet Neurology, 10(1), 75&#x2013;82. 10.1016/S1474-4422(10)70224-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(10)70224-6</ArticleId><ArticleId IdType="pubmed">21035400</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisen, A. , Kiernan, M. , Mitsumoto, H. , &amp; Swash, M. (2014). Amyotrophic lateral sclerosis: A long preclinical period? Journal of Neurology, Neurosurgery, and Psychiatry, 85(11), 1232&#x2013;1238. 10.1136/jnnp-2013-307135</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2013-307135</ArticleId><ArticleId IdType="pubmed">24648037</ArticleId></ArticleIdList></Reference><Reference><Citation>Gribsholt, S. B. , Pedersen, L. , Richelsen, B. , &amp; Thomsen, R. W. (2019). Validity of ICD&#x2010;10 diagnoses of overweight and obesity in Danish hospitals. Clinical Epidemiology, 11, 845&#x2013;854. 10.2147/CLEP.S214909</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/CLEP.S214909</ArticleId><ArticleId IdType="pmc">PMC6748036</ArticleId><ArticleId IdType="pubmed">31572015</ArticleId></ArticleIdList></Reference><Reference><Citation>Haire&#x2010;Joshu, D. , Glasgow, R. E. , &amp; Tibbs, T. L. (1999). Smoking and diabetes. Diabetes Care, 22(11), 1887&#x2013;1898. 10.2337/diacare.22.11.1887</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/diacare.22.11.1887</ArticleId><ArticleId IdType="pubmed">10546025</ArticleId></ArticleIdList></Reference><Reference><Citation>Heide&#x2010;J&#xf8;rgensen, U. , Adelborg, K. , Kahlert, J. , S&#xf8;rensen, H. T. , &amp; Pedersen, L. (2018). Sampling strategies for selecting general population comparison cohorts. Clinical Epidemiology, 10, 1325&#x2013;1337. 10.2147/CLEP.S164456</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/CLEP.S164456</ArticleId><ArticleId IdType="pmc">PMC6165733</ArticleId><ArticleId IdType="pubmed">30310326</ArticleId></ArticleIdList></Reference><Reference><Citation>Hollinger, S. K. , Okosun, I. S. , &amp; Mitchell, C. S. (2016). Antecedent disease and amyotrophic lateral sclerosis: What is protecting whom? Frontier Neurology, 7, 47. 10.3389/fneur.2016.00047</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2016.00047</ArticleId><ArticleId IdType="pmc">PMC4810157</ArticleId><ArticleId IdType="pubmed">27065942</ArticleId></ArticleIdList></Reference><Reference><Citation>Ingre, C. , Roos, P. M. , Piehl, F. , Kamel, F. , &amp; Fang, F. (2015). Risk factors for amyotrophic lateral sclerosis. Clinical Epidemiology, 7, 181&#x2013;193. 10.2147/CLEP.S37505</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/CLEP.S37505</ArticleId><ArticleId IdType="pmc">PMC4334292</ArticleId><ArticleId IdType="pubmed">25709501</ArticleId></ArticleIdList></Reference><Reference><Citation>Johannesdottir, S. A. , Horv&#xe1;th&#x2010;Puh&#xf3;, E. , Ehrenstein, V. , Schmidt, M. , Pedersen, L. , &amp; S&#xf8;rensen, H. T. (2012). Existing data sources for clinical epidemiology: The danish national database of reimbursed prescriptions. Clinical Epidemiology, 4, 303&#x2013;313. 10.2147/CLEP.S37587</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/CLEP.S37587</ArticleId><ArticleId IdType="pmc">PMC3508607</ArticleId><ArticleId IdType="pubmed">23204870</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaneb, H. M. , Sharp, P. S. , Rahmani&#x2010;Kondori, N. , &amp; Wells, D. J. (2011). Metformin treatment has no beneficial effect in a dose&#x2010;response survival study in the SOD1(G93A) mouse model of ALS and is harmful in female mice. PLoS ONE, 6(9), e24189. 10.1371/journal.pone.0024189</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0024189</ArticleId><ArticleId IdType="pmc">PMC3164704</ArticleId><ArticleId IdType="pubmed">21909419</ArticleId></ArticleIdList></Reference><Reference><Citation>Kioumourtzoglou, M.&#x2010;A. , Rotem, R. S. , Seals, R. M. , Gredal, O. , Hansen, J. , &amp; Weisskopf, M. G. (2015). Diabetes mellitus, obesity, and diagnosis of amyotrophic lateral sclerosis: A population&#x2010;based study. JAMA Neurology, 72(8), 905&#x2013;911. 10.1001/jamaneurol.2015.0910</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2015.0910</ArticleId><ArticleId IdType="pmc">PMC4975611</ArticleId><ArticleId IdType="pubmed">26030836</ArticleId></ArticleIdList></Reference><Reference><Citation>Kioumourtzoglou, M.&#x2010;A. , Seals, R. M. , Himmerslev, L. , Gredal, O. , Hansen, J. , &amp; Weisskopf, M. G. (2015). Comparison of diagnoses of amyotrophic lateral sclerosis by use of death certificates and hospital discharge data in the Danish population. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 16(3&#x2013;4), 224&#x2013;229. 10.3109/21678421.2014.988161</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2014.988161</ArticleId><ArticleId IdType="pmc">PMC4675622</ArticleId><ArticleId IdType="pubmed">25946516</ArticleId></ArticleIdList></Reference><Reference><Citation>Lekoubou, A. , Matsha, T. E. , Sobngwi, E. , &amp; Kengne, A. P. (2014). Effects of diabetes mellitus on amyotrophic lateral sclerosis: A systematic review. BMC Research Notes, 7, 171. 10.1186/1756-0500-7-171</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1756-0500-7-171</ArticleId><ArticleId IdType="pmc">PMC3987838</ArticleId><ArticleId IdType="pubmed">24661645</ArticleId></ArticleIdList></Reference><Reference><Citation>Mariosa, D. , Kamel, F. , Bellocco, R. , Ronnevi, L. &#x2010; O. , Almqvist, C. , Larsson, H. , Ye, W. , &amp; Fang, F. (2020). Antidiabetics, statins and the risk of amyotrophic lateral sclerosis. European Journal of Neurology, 27(6), 1010&#x2013;1016. 10.1111/ene.14190</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14190</ArticleId><ArticleId IdType="pubmed">32097525</ArticleId></ArticleIdList></Reference><Reference><Citation>Mariosa, D. , Kamel, F. , Bellocco, R. , Ye, W. , &amp; Fang, F. (2015). Association between diabetes and amyotrophic lateral sclerosis in Sweden. European Journal of Neurology, 22(11), 1436&#x2013;1442. 10.1111/ene.12632</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.12632</ArticleId><ArticleId IdType="pmc">PMC4506907</ArticleId><ArticleId IdType="pubmed">25600257</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell, C. S. , Hollinger, S. K. , Goswami, S. D. , Polak, M. A. , Lee, R. H. , &amp; Glass, J. D. (2015). Antecedent disease is less prevalent in amyotrophic lateral sclerosis. Neurodegenerative Diseases, 15(2), 109&#x2013;113. 10.1159/000369812</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000369812</ArticleId><ArticleId IdType="pmc">PMC4417009</ArticleId><ArticleId IdType="pubmed">25720304</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Reilly, &#xc9;. J. , Wang, H. , Weisskopf, M. G. , Fitzgerald, K. C. , Falcone, G. , McCullough, M. L. , Thun, M. , Park, Y. , Kolonel, L. N. , &amp; Ascherio, A. (2013). Premorbid body mass index and risk of amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 14(3), 205&#x2013;211. 10.3109/21678421.2012.735240</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2012.735240</ArticleId><ArticleId IdType="pmc">PMC3615420</ArticleId><ArticleId IdType="pubmed">23134505</ArticleId></ArticleIdList></Reference><Reference><Citation>

Schmidt, M.
, 
Pedersen, L.
, &amp; 
S&#xf8;rensen, H. T.
 (2014). The Danish Civil Registration System as a tool in epidemiology. European Journal of Epidemiology, 29(8), 541&#x2013;549. https://doi.org.ez.statsbiblioteket.dk:2048/10.1007/s10654&#x2010;014&#x2010;9930&#x2010;3
</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10654-014-9930-3</ArticleId><ArticleId IdType="pubmed">24965263</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt, M. , Schmidt, S. A. J. , Adelborg, K. , Sundb&#xf8;ll, J. , Laugesen, K. , Ehrenstein, V. , &amp; S&#xf8;rensen, H. T. (2019). The Danish health care system and epidemiological research: From health care contacts to database records. Clinical Epidemiology, 11, 563&#x2013;591. 10.2147/CLEP.S179083</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/CLEP.S179083</ArticleId><ArticleId IdType="pmc">PMC6634267</ArticleId><ArticleId IdType="pubmed">31372058</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt, M. , Schmidt, S. A. J. , Sandegaard, J. L. , Ehrenstein, V. , Pedersen, L. , &amp; S&#xf8;rensen, H. T. (2015). The Danish National Patient Registry: A review of content, data quality, and research potential. Clinical Epidemiology, Published online November 2015, 449. 10.2147/CLEP.S91125</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/CLEP.S91125</ArticleId><ArticleId IdType="pmc">PMC4655913</ArticleId><ArticleId IdType="pubmed">26604824</ArticleId></ArticleIdList></Reference><Reference><Citation>Seelen, M. , van Doormaal, P. T. C. , Visser, A. E. , Huisman, M. H. , Roozekrans, M. H. , de Jong, S. W. , van der Kooi, A. J. , de Visser, M. , Voermans, N. C. , Veldink, J. H. , &amp; van den Berg, L. H. (2014). Prior medical conditions and the risk of amyotrophic lateral sclerosis. Journal of Neurology, 261(10), 1949&#x2013;1956. 10.1007/s00415-014-7445-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-014-7445-1</ArticleId><ArticleId IdType="pubmed">25059395</ArticleId></ArticleIdList></Reference><Reference><Citation>Skajaa, N. , Bakos, I. , Horv&#xe1;th&#x2010;Puh&#xf3;, E. , Henderson, V. W. , Lash, T. L. , &amp; S&#xf8;rensen, H. T. (2021). Statin initiation and risk of amyotrophic lateral sclerosis: A Danish population&#x2010;based cohort study. Epidemiology Cambridge, Mass, 32(5), 756&#x2013;762. 10.1097/EDE.0000000000001384</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EDE.0000000000001384</ArticleId><ArticleId IdType="pubmed">34183532</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun, H. , Knippenberg, S. , Thau, N. , Ragancokova, D. , K&#xf6;rner, S. , Huang, D. , Dengler, R. , D&#xf6;hler, K. , &amp; Petri, S. (2013). Therapeutic potential of N&#x2010;acetyl&#x2010;glucagon&#x2010;like peptide&#x2010;1 in primary motor neuron cultures derived from non&#x2010;transgenic and SOD1&#x2010;G93A ALS mice. Cellular and Molecular Neurobiology, 33(3), 347&#x2013;357. 10.1007/s10571-012-9900-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10571-012-9900-9</ArticleId><ArticleId IdType="pubmed">23271639</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun, Y. , Lu, C.&#x2010;J. , Chen, R.&#x2010;C. , Hou, W.&#x2010;H. , &amp; Li, C.&#x2010;Y. (2015). Risk of amyotrophic lateral sclerosis in patients with diabetes: A nationwide population&#x2010;based cohort study. Journal of Epidemiology, 25(6), 445&#x2013;451. 10.2188/jea.JE20140176</Citation><ArticleIdList><ArticleId IdType="doi">10.2188/jea.JE20140176</ArticleId><ArticleId IdType="pmc">PMC4444499</ArticleId><ArticleId IdType="pubmed">25947580</ArticleId></ArticleIdList></Reference><Reference><Citation>Sutedja, N. A. , van der Schouw, Y. T. , Fischer, K. , Sizoo, E. M. , Huisman, M. H. B. , Veldink, J. H. , &amp; Van den Berg, L. H. (2011). Beneficial vascular risk profile is associated with amyotrophic lateral sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry, 82(6), 638&#x2013;642. 10.1136/jnnp.2010.236752</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2010.236752</ArticleId><ArticleId IdType="pubmed">21471184</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai, C.&#x2010;P. , Lee, J. K.&#x2010;W. , &amp; Lee, C. T.&#x2010;C. (2019). Type II diabetes mellitus and the incidence of amyotrophic lateral sclerosis. Journal of Neurology, 266(9), 2233&#x2013;2243. 10.1007/s00415-019-09405-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-019-09405-x</ArticleId><ArticleId IdType="pubmed">31152300</ArticleId></ArticleIdList></Reference><Reference><Citation>VanderWeele, T. J. , &amp; Ding, P. (2017). Sensitivity analysis in observational research: Introducing the E&#x2010;value. Annals of Internal Medicine, 167(4), 268&#x2013;274. 10.7326/M16-2607</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M16-2607</ArticleId><ArticleId IdType="pubmed">28693043</ArticleId></ArticleIdList></Reference><Reference><Citation>Vandoorne, T. , De Bock, K. , &amp; Van Den Bosch, L. (2018). Energy metabolism in ALS: An underappreciated opportunity? Acta Neuropathologica, 135(4), 489&#x2013;509. 10.1007/s00401-018-1835-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1835-x</ArticleId><ArticleId IdType="pmc">PMC5978930</ArticleId><ArticleId IdType="pubmed">29549424</ArticleId></ArticleIdList></Reference><Reference><Citation>van Es, M. A. , Hardiman, O. , Chio, A. , Al&#x2010;Chalabi, A. , Pasterkamp, R. J. , Veldink, J. H. , &amp; van den Berg, L. H. (2017). Amyotrophic lateral sclerosis. Lancet, London, England, 390(10107), 2084&#x2013;2098. 10.1016/S0140-6736(17)31287-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)31287-4</ArticleId><ArticleId IdType="pubmed">28552366</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>